Phase II Proof of Concept Trial to Determine Efficacy of Fexinidazole in Visceral Leishmaniasis Patients in Sudan

Trial Profile

Phase II Proof of Concept Trial to Determine Efficacy of Fexinidazole in Visceral Leishmaniasis Patients in Sudan

Discontinued
Phase of Trial: Phase II

Latest Information Update: 21 Sep 2015

At a glance

  • Drugs Fexinidazole (Primary)
  • Indications Visceral leishmaniasis
  • Focus Proof of concept; Therapeutic Use
  • Most Recent Events

    • 17 Sep 2015 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 25 Nov 2013 New trial record
    • 12 Nov 2013 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top